Atlas Trials

Irreversible Electroporation(IRE) For Unresectable Renal Tumors

Clinical trial NCT02335827 · COMPLETED

Trial details

NCT number
NCT02335827
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Renal Tumor
Start date
2015-01-01
Primary completion
2020-05-20
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.